JACC: Journal of the American College of Cardiology
ORIGINAL INVESTIGATIONSEditorial CommentEditorial CommentEditorial CommentEditorial CommentEditorial…
Related Articles
SGLT2 Inhibitors and Major Adverse CV Outcomes – American College of Cardiology
Debabrata Mukherjee, MD, FACC
Advocacy at the ACC – American College of Cardiology
The ACC is leading the transformation of care by advocating for a quality driven health care system, provider stability, population health and the future of…
FDA Update: Heartmate II and Heartmate 3 LVAS Recalled Due to Obstruction – American College of Cardiology
The U.S. Food and Drug Administration (FDA) announced on April 15 that Abbott/Thoratec Corp. is recalling the Heartmate II and Heartmate 3 Left Ventricular Assist…
Realizing Our Vision: ACC’s Next 5-Year Strategic Plan
∗Address for correspondence: Ms Cathleen Biga, American Coll ege of Cardiology, 2400 N Street, NW, Washington, DC 20037, USA. E-mail: E-mail Address: [email protected] As…
ACC President Series | Heart-to-Heart – American College of Cardiology
Join ACC President B. Hadley Wilson, MD, FACC (@HadleyWilsonMD), for his new Heart-to-Heart presidential chat series focused on ACC members and their inspiring work to…
Lp(a) and CV Risk Reduction With Icosapent Ethyl – American College of Cardiology
Elizabeth A. Jackson, MD, FACC
Catheter-Based Therapy for High- or Intermediate-Risk PE – American College of Cardiology
Debabrata Mukherjee, MD, FACC
ACC Middle East 2024 – American College of Cardiology
United by our shared commitment of transforming cardiovascular care, the American College of Cardiology (ACC) and the Egyptian Society of Cardiology invite you to join…